Enhanced susceptibility to Leishmania infection in resistant mice in the absence of immediate early response gene X-1

Journal of Immunology

Volumn 183, Issue 12, 2009, Pages 7994-8003

  Akilov, Oleg E ^a   Ustyugova, Irina V ^a   Zhi, Liang ^a   Hasan, Tayyaba ^a   Wu, Mei X ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 17; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; IEX 1 PROTEIN, MOUSE; IEX-1 PROTEIN, MOUSE; IMMEDIATE EARLY PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CELL POLARITY; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; GENE FUNCTION; GENE MUTATION; IMMEDIATE EARLY GENE; INFECTION SENSITIVITY; INFLAMMATION; MACROPHAGE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; SKIN LEISHMANIASIS; T LYMPHOCYTE; TH1 CELL; TH2 CELL; WILD TYPE; ANIMAL; C57BL MOUSE; CELL CULTURE; GENETIC PREDISPOSITION; GENETICS; HOSPITALIZATION; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; LEISHMANIA MAJOR; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY;

ANIMALS; CELLS, CULTURED; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMEDIATE-EARLY PROTEINS; IMMUNITY, INNATE; INFLAMMATION MEDIATORS; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; SEVERITY OF ILLNESS INDEX;

EID: 76249133497     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0900866     Document Type: Article

References (44)

1. Sacks, D., and C. Anderson. 2004. Re-examination of the immunosuppressive mechanisms mediating non-cure of Leishmania infection in mice. Immunol. Rev. 201: 225-238.
2. Mauel, J. 1990. Macrophage-parasite interactions in Leishmania infections. J. Leukocyte Biol. 47: 187-193.
3. Ribeiro-de-Jesus, A., R. P. Almeida, H. Lessa, O. Bacellar, and E. M. Carvalho. 1998. Cytokine profile and pathology in human leishmaniasis. Braz. J. Med. Biol. Res. 31: 143-148.
4. Locksley, R. M., and J. A. Louis. 1992. Immunology of leishmaniasis. Curr. Opin. Immunol. 4: 413-418.
5. Noben-Trauth, N., W. E. Paul, and D. L. Sacks. 1999. IL-4- and IL-4 receptor-deficient BALB/c mice reveal differences in susceptibility to Leishmania major parasite substrains. J. Immunol. 162: 6132-6140. (Pubitemid 29314974)
6. Gorelik, L., S. Constant, and R. A. Flavell. 2002. Mechanism of transforming growth factor β-induced inhibition of T helper type 1 differentiation. J. Exp. Med. 195: 1499-1505.
7. Li, J., C. A. Hunter, and J. P. Farrell. 1999. Anti-TGF-β treatment promotes rapid healing of Leishmania major infection in mice by enhancing in vivo nitric oxide production. J. Immunol. 162: 974-979. (Pubitemid 29035423)
8. Cua, D. J., J. Sherlock, Y. Chen, C. A. Murphy, B. Joyce, B. Seymour, L. Lucian, W. To, S. Kwan, T. Churakova, et al. 2003. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421: 744-748.
9. Santarlasci, V., L. Maggi, M. Capone, F. Frosali, V. Querci, R. De Palma, F. Liotta, L. Cosmi, E. Maggi, S. Romagnani, and F. Annunziato. 2009. TGF-β indirectly favors the development of human Th17 cells by inhibiting Th1 cells. Eur. J. Immunol. 39: 207-215.
10. Lopez Kostka, S., S. Dinges, K. Griewank, Y. Iwakura, M. C. Udey, and E. von Stebut. 2009. IL-17 promotes progression of cutaneous leishmaniasis in susceptible mice. J. Immunol. 182: 3039-3046.
11. Shen, L., L. Zhi, W. Hu, and M. X. Wu. 2008. IEX-1 targets mitochondrial F1Fo-ATPase inhibitor for degradation. Cell Death Differ. 16: 603-612.
12. Zhang, Y., S. F. Schlossman, R. A. Edwards, C. N. Ou, J. Gu, and M. X. Wu. 2002. Impaired apoptosis, extended duration of immune responses, and a lupus-like autoimmune disease in IEX-1-transgenic mice. Proc. Natl. Acad. Sci. USA 99: 878-883.
13. Spath, G. F., and S. M. Beverley. 2001. A lipophosphoglycan-independent method for isolation of infective Leishmania metacyclic promastigotes by density gradient centrifugation. Exp. Parasitol. 99: 97-103.
14. Belkaid, Y., S. Kamhawi, G. Modi, J. Valenzuela, N. Noben-Trauth, E. Rowton, J. Ribeiro, and D. L. Sacks. 1998. Development of a natural model of cutaneous leishmaniasis: powerful effects of vector saliva and saliva preexposure on the long-term outcome of Leishmania major infection in the mouse ear dermis. J. Exp. Med. 188: 1941-1953.
15. Flamant, S., M. Lebastard, P. Pescher, C. Besmond, G. Milon, and G. Marchal. 2003. Enhanced cloning efficiency of mouse bone marrow macrophage progenitors correlates with increased content of CSF-1 receptor of their progeny at low oxygen tension. Microbes Infect. 5: 1064-1069. (Pubitemid 37211467)
16. Belkaid, Y. 2007. Regulatory T cells and infection: a dangerous necessity. Nat. Rev. Immunol. 7: 875-888.
17. + regulatory T cells suppress differentiation and functions of Th1 and Th2 cells, Leishmania major infection, and colitis in mice. J. Immunol. 170: 394-399.
18. Iyengar, R., D. J. Stuehr, and M. A. Marletta. 1987. Macrophage synthesis of nitrite, nitrate, and N-nitrosamines: precursors and role of the respiratory burst. Proc. Natl. Acad. Sci. USA 84: 6369-6373.
19. Green, S. J., L. F. Scheller, M. A. Marletta, M. C. Seguin, F. W. Klotz, M. Slayter, B. J. Nelson, and C. A. Nacy. 1994. Nitric oxide: cytokine-regulation of nitric oxide in host resistance to intracellular pathogens. Immunol. Lett. 43: 87-94.
20. Mauel, J., and A. Ransijn. 1997. Leishmania spp.: mechanisms of toxicity of nitrogen oxidation products. Exp. Parasitol. 87: 98-111.
21. Green, S. J., M. S. Meltzer, J. B. Hibbs, Jr., and C. A. Nacy. 1990. Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism. J. Immunol. 144: 278-283.
22. Assreuy, J., F. Q. Cunha, M. Epperlein, A. Noronha-Dutra, C. A. O'Donnell, F. Y. Liew, and S. Moncada. 1994. Production of nitric oxide and superoxide by activated macrophages and killing of Leishmania major. Eur. J. Immunol. 24: 672-676.
23. Kuroda, S., M. Nishio, T. Sasaki, Y. Horie, K. Kawahara, M. Sasaki, M. Natsui, T. Matozaki, H. Tezuka, T. Ohteki, et al. 2008. Effective clearance of intracellular Leishmania major in vivo requires Pten in macrophages. Eur. J. Immunol. 38: 1331-1340.
24. Liew, F. Y., Y. Li, and S. Millott. 1990. Tumor necrosis factor- synergizes with IFN-γ in mediating killing of Leishmania major through the induction of nitric oxide. J. Immunol. 145: 4306-4310.
25. De Kossodo, S., G. E. Grau, J. A. Louis, and I. Muller. 1994. Tumor necrosis factor (TNF-α) and TNF-β and their receptors in experimental cutaneous leishmaniasis. Infect. Immun. 62: 1414-1420.
26. Allenbach, C., P. Launois, C. Mueller, and F. Tacchini-Cottier. 2008. An essential role for transmembrane TNF in the resolution of the inflammatory lesion induced by Leishmania major infection. Eur. J. Immunol. 38: 720-731.
27. Drapier, J. C., J. Wietzerbin, and J. B. Hibbs, Jr. 1988. Interferon-γ and tumor necrosis factor induce the L-arginine-dependent cytotoxic effector mechanism in murine macrophages. Eur. J. Immunol. 18: 1587-1592.
28. Sommer, S. L., T. J. Berndt, E. Frank, J. B. Patel, M. M. Redfield, X. Dong, M. D. Griffin, J. P. Grande, J. M. van Deursen, G. C. Sieck, et al. 2006. Elevated blood pressure and cardiac hypertrophy after ablation of the gly96/IEX-1 gene. J. Appl. Physiol. 100: 707-716.
29. Zhang, Y., M. J. Finegold, F. Porteu, P. Kanteti, and M. X. Wu. 2003. Development of T-cell lymphomas in Emu-IEX-1 mice. Oncogene 22: 6845-6851.
30. + regulatory T cells control Leishmania major persistence and immunity. Nature 420: 502-507.
31. Belkaid, Y., S. Mendez, R. Lira, N. Kadambi, G. Milon, and D. Sacks. 2000. A natural model of Leishmania major infection reveals a prolonged "silent" phase of parasite amplification in the skin before the onset of lesion formation and immunity. J. Immunol. 165: 969-977.
32. + T cells. J. Immunol. 169: 3232-3241.
33. Veras, P. S., M. Welby-Borges, C. D. de Santana, J. Nihei, F. Cardillo, and L. A. de Freitas. 2006. Leishmania amazonensis: participation of regulatory T and B cells in the in vitro priming (PIV) of CBA/J spleen cells susceptible response. Exp. Parasitol. 113: 201-205.
34. Beil, W. J., G. Meinardus-Hager, D. C. Neugebauer, and C. Sorg. 1992. Differences in the onset of the inflammatory response to cutaneous leishmaniasis in resistant and susceptible mice. J. Leukocyte Biol. 52: 135-142.
35. Mills, K. H. 2008. Induction, function and regulation of IL-17-producing T cells. Eur. J. Immunol. 38: 2636-2649.
36. + Th2 response in BALB/c mice infected with Leishmania major. J. Immunol. 165: 2628-2636.
37. Ribeiro-Gomes, F. L., A. C. Otero, N. A. Gomes, M. C. Moniz-De-Souza, L. Cysne-Finkelstein, A. C. Arnholdt, V. L. Calich, S. G. Coutinho, M. F. Lopes, and G. A. DosReis. 2004. Macrophage interactions with neutrophils regulate Leishmania major infection. J. Immunol. 172: 4454-4462.
38. Titus, R. G., B. Sherry, and A. Cerami. 1989. Tumor necrosis factor plays a protective role in experimental murine cutaneous leishmaniasis. J. Exp. Med. 170: 2097-2104.
39. Green, S. J., R. M. Crawford, J. T. Hockmeyer, M. S. Meltzer, and C. A. Nacy. 1990. Leishmania major amastigotes initiate the L-arginine-dependent killing mechanism in IFN-γ-stimulated macrophages by induction of tumor necrosis factor-α. J. Immunol. 145: 4290-4297.
40. Pizzorni, C., M. E. Secchi, and M. Cutolo. 2007. [Leishmaniasis in rheumatoid arthritis.] Reumatismo 59: 235-239.
41. Kropf, P., M. A. Freudenberg, M. Modolell, H. P. Price, S. Herath, S. Antoniazi, C. Galanos, D. F. Smith, and I. Muller. 2004. Toll-like receptor 4 contributes to efficient control of infection with the protozoan parasite Leishmania major. Infect. Immun. 72: 1920-1928.
42. De Veer, M. J., J. M. Curtis, T. M. Baldwin, J. A. DiDonato, A. Sexton, M. J. McConville, E. Handman, and L. Schofield. 2003. MyD88 is essential for clearance of Leishmania major: possible role for lipophosphoglycan and Toll-like receptor 2 signaling. Eur. J. Immunol. 33: 2822-2831.
43. Hayashi, T., Y. Ueno, and T. Okamoto. 1993. Oxidoreductive regulation of nuclear factor κB: involvement of a cellular reducing catalyst thioredoxin. J. Biol. Chem. 268: 11380-11388.
44. Toledano, M. B., and W. J. Leonard. 1991. Modulation of transcription factor NF-κB binding activity by oxidation-reduction in vitro. Proc. Natl. Acad. Sci. USA 88: 4328-4332.